◆英語タイトル:Revance Therapeutics Inc (RVNC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7327
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fasciitis among others. It also provides RT001, a topical gel formulation of daxibotulinumtoxinA, which is designed to eliminate the use of needles. Revance Therapeutics develops products for multiple aesthetic and therapeutic applications. The company utilizes TransMTS platform technology for the development of its products. It offers products for dermatology, neurology, musculoskeletal disorders, urology and ophthalmology. Revance Therapeutics is headquartered in Newark, California, the US.
Revance Therapeutics Inc (RVNC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Revance Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Revance Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Revance Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Revance Therapeutics Raises US$10 Million In Venture Financing 10
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 11
Equity Offering 13
Revance Therapeutics Plans to Raise upto USD125 Million in Public Offering of Shares 13
Revance Therapeutics Raises USD167.1 Million in Public Offering of Shares 14
Revance Therapeutics Raises USD134.6 Public Offering of Shares 16
Revance Therapeutics Completes IPO For US$110.4 Million 18
Revance Therapeutics Inc – Key Competitors 20
Revance Therapeutics Inc – Key Employees 21
Revance Therapeutics Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 02, 2018: Revance releases second quarter 2018 results 23
May 08, 2018: Revance Releases First Quarter 2018 Results 24
Feb 28, 2018: Revance Announces Fourth Quarter and Full Year 2017 Financial Results 25
Aug 03, 2017: Revance Releases Second Quarter 2017 Results 26
May 09, 2017: Revance Releases First Quarter 2017 Results 27
Feb 27, 2017: Revance Releases Fourth Quarter and Full Year 2016 Results 28
Corporate Communications 30
Oct 11, 2018: Revance Therapeutics appoints Tobin C. Schilke as chief financial officer 30
Sep 20, 2018: Revance receives great place to work Certification 31
May 09, 2018: Revance Therapeutics Announces Two Recent Additions to Its Management Team 32
May 01, 2018: Revance Therapeutics Appoints Caryn McDowell As SVP, General Counsel & Corporate Secretary 33
Sep 06, 2017: Revance Appoints Mark Foley to its Board of Directors 34
Aug 02, 2017: Revance appoints new chief commercial officer and president of Aesthetics & Therapeutics 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Revance Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Revance Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Revance Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Revance Therapeutics Raises US$10 Million In Venture Financing 10
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 11
Revance Therapeutics Plans to Raise upto USD125 Million in Public Offering of Shares 13
Revance Therapeutics Raises USD167.1 Million in Public Offering of Shares 14
Revance Therapeutics Raises USD134.6 Public Offering of Shares 16
Revance Therapeutics Completes IPO For US$110.4 Million 18
Revance Therapeutics Inc, Key Competitors 20
Revance Therapeutics Inc, Key Employees 21
Revance Therapeutics Inc, Subsidiaries 22
List of Figures
Revance Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Revance Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Revance Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8